bullish

Pharmaceuticals: Indian CRDMOs at a pivotal point, scale-up key

190 Views07 Jan 2026 09:24
Broker
The Indian Contract Research, Development, and Manufacturing Organizations (CRDMO) market is poised to grow rapidly at a CAGR of ~13.4% over 2024-2029E
What is covered in the Full Insight:
  • Introduction to Indian CRDMOs
  • Growth Drivers and Opportunities
  • Challenges Ahead
  • Market Projections
  • Investment Recommendations
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
  • Unlock research summaries
  • Follow top, independent analysts
  • Receive personalised alerts
  • Access Analytics, Events and more

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 196-minute read)
Discussions
(Paid Plans Only)
chart-bar
  • Pharmaceuticals: Indian CRDMOs at a pivotal point, scale-up key
    07 Jan 2026
x